Mineralys Therapeutics, Inc. Common Stock Stock Performance
as on May 14, 2026 at 2:15 pm IST
Day's Low
Day's High
$26.71$29.11
0.56%
Downside
8.38%
Upside
52 Week's Low
52 Week's High
$12.59$47.6553.13%
Downside
77.40%
Upside
Mineralys Therapeutics, Inc. Common Stock share price movements today
- Previous Close
- $29.26
- Open
- $29.00
- Volume
- 1.7M
- Day's Low - High
- $26.71 - $29.11
- 52 Week Low - High
- $12.59 - $47.65
Mineralys Therapeutics, Inc. Common Stock Historical Returns
- 1 Month Return
- + 7.1 %
- 3 Month Return
- + 6.01 %
- 1 Year Return
- + 93.65 %
- 3 Year Return
- + 81.18 %
- 5 Year Return
- 0 %
Mineralys Therapeutics, Inc. Common Stock Stock Fundamentals & Key Indicators
Check Mineralys Therapeutics, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.5B
EPS (TTM)
-2.1838
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-171.4M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-30.99%
Mineralys Therapeutics, Inc. Common Stock vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Mineralys Therapeutics, Inc. Common Stock with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.5B | NA | NA | 0.00% | |
| BUY | $38.0B | 115.2% | 71.39 | 12.55% | |
| NA | $32.7B | NA | 71.44 | 8.94% | |
| BUY | $110.4B | 106.5% | 25.84 | 35.51% | |
| BUY | $74.7B | 40.03% | 17.39 | 29.65% |
Stock Returns calculator for Mineralys Therapeutics, Inc. Common Stock Stock including INR - Dollar returns
The Mineralys Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Mineralys Therapeutics, Inc. Common Stock investment value today
Current value as on today
₹1,99,506
Returns
₹99,506
(+99.51%)
Returns from Mineralys Therapeutics, Inc. Common Stock Stock
₹77,763 (+77.76%)
Dollar Impact
₹21,743 (+21.74%)
Analyst Recommendation on Mineralys Therapeutics, Inc. Common Stock Stock
Based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Mineralys Therapeutics, Inc. Common Stock. Average target price of $48.5
Mineralys Therapeutics, Inc. Common Stock Share Price Target
Get share price movements and forecasts by analysts on Mineralys Therapeutics, Inc. Common Stock.
What analysts predicted
44.62%UPSIDE
Target Price
$48.5
Current Price
$26.86
Analyzed by
13 Analysts
Target
$48.50
Mineralys Therapeutics, Inc. Common Stock target price $48.5, a slight upside of 44.62% compared to current price of $26.86. According to 13 analysts rating.
Indian Investors' Interest in Mineralys Therapeutics, Inc. Common Stock Stock
Search interest for Mineralys Therapeutics, Inc. Common Stock Stock has increased by 167% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:167% versus previous 30 day period
Mineralys Therapeutics, Inc. Common Stock Quarterly Profit & Loss
All numbers in Millions USD
Mineralys Therapeutics, Inc. Common Stock Annual Profit & Loss
All numbers in Millions USD
Mineralys Therapeutics, Inc. Common Stock Quarterly Cash Flow
All numbers in Millions USD
Mineralys Therapeutics, Inc. Common Stock Annual Cash Flow
All numbers in Millions USD
Insights on Mineralys Therapeutics, Inc. Common Stock
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 year, MLYS stock has moved up by 93.6%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, MLYS has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, MLYS has outperformed top 5 stocks with highest market-cap in its industry
About Mineralys Therapeutics, Inc. Common Stock
| Organisation | Mineralys Therapeutics, Inc. Common Stock |
| Headquarters | 150 N. Radnor Chester Road, Radnor, PA, United States, 19087 |
| Industry | Biotechnology |
| CEO | Mr. Jon Congleton |
| E-voting on shares | Click here to vote |
Key Management of Mineralys Therapeutics, Inc. Common Stock
Name | Title |
|---|---|
Dr. David M. Rodman M.D. | Chief Medical Officer |
Mr. Jeffrey A. Munsie J.D. | Chief Legal Officer |
Dr. Robert McKean Ph.D. | Senior Vice President of CMC |
Ms. Danielle Mahoney | Senior Vice President of Quality Assurance |
Mr. Eric J. Warren R.Ph. | Chief Commercial Officer |
Mr. Jon Congleton | President, CEO & Director |
Dr. Brian Taylor Slingsby M.D., M.P.H., Ph.D. | Founder & Executive Director |
Mr. Adam Scott Levy | CFO & Secretary |
Ms. Jessica Ibbitson | Executive Vice President of Operations |
Ms. Tiffany Ellen Burt | Senior Vice President of Medical Affairs |
FAQs
What is Mineralys Therapeutics, Inc. Common Stock share price today?
Mineralys Therapeutics, Inc. Common Stock share price today is $26.86 as on at the close of the market. Mineralys Therapeutics, Inc. Common Stock share today touched a day high of $29.11 and a low of $26.71.
What is the 52 week high and 52 week low for Mineralys Therapeutics, Inc. Common Stock share?
Mineralys Therapeutics, Inc. Common Stock share touched a 52 week high of $47.65 on and a 52 week low of $12.59 on . Mineralys Therapeutics, Inc. Common Stock stock price today i.e. is closed at $26.86,which is 43.63% down from its 52 week high and 113.34% up from its 52 week low.
What is Mineralys Therapeutics, Inc. Common Stock's market capitalisation today?
Mineralys Therapeutics, Inc. Common Stock market capitalisation is $0.00T as on .
How to invest in Mineralys Therapeutics, Inc. Common Stock Stock (MLYS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Mineralys Therapeutics, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mineralys Therapeutics, Inc. Common Stock Shares that will get you 0.0558 shares as per Mineralys Therapeutics, Inc. Common Stock share price of $26.86 per share as on May 14, 2026 at 8:45 am IST.
What is the minimum amount required to buy Mineralys Therapeutics, Inc. Common Stock Stock (MLYS) from India?
Indian investors can start investing in Mineralys Therapeutics, Inc. Common Stock (MLYS) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Mineralys Therapeutics, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on ).
Based on Mineralys Therapeutics, Inc. Common Stock share’s latest price of $26.86 as on May 14, 2026 at 8:45 am IST, you will get 0.3723 shares of Mineralys Therapeutics, Inc. Common Stock. Learn more about
fractional shares .